CHCarol Hlela

Carol Hlela

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carol Hlela has a total of 173 co-authors. Here are the top co-authors by number of shared publications:

  • Nonhlanhla Lunjani

    Swiss Institute of Allergy and Asthma Research (SIAF) University of Zürich Davos Switzerland

    6 shared publications
  • Nonhlanhla Patience Khumalo

    MRC-SA Wound Healing and Keloid Research Unit, Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa

    6 shared publications
  • Maresa Botha

    Division of Paediatric Allergy Department of Paediatrics Faculty of Health Sciences University of Cape Town Cape Town South Africa

    5 shared publications
  • Michael Levin

    Division of Paediatric Allergology, University of Cape Town, Cape Town, South Africa

    5 shared publications
  • Avumile Mankahla

    Division of Dermatology Department of Medicine and Pharmacology Walter Sisulu University Mthatha South Africa

    4 shared publications
  • Rannakoe Lehloenya

    Division of Dermatology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa

    4 shared publications

Latest Publications

  • Open Access

    Multimodal protective and susceptibility clusters in paediatric atopic dermatitis: A machine learning-based, data-driven observational study

    by Damir Zhakparov, Nonhlanhla Lunjani, Marco Schmid, Kathleen Moriarty, Damian Roquero, Anita Dreher, Jeannette I. Heldstab-Kast, Kari C. Nadeau, Cezmi Akdis, Michael Levin, et al.

    Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease that typically develops in early childhood. Differences in AD prevalence and allergy sensitisation patterns have been observed in African populations, including the AmaXhosa population in South Africa, suggesting alternative pathogenic and immune mechanisms underlying AD. Differences in AD prevalence have also been documented between urban and rural communities, making AmaXhosa children, who share a common ethnogenetic background but differ in environmental exposures, a unique population in which to investigate environmental and immune mechanisms underlying AD. To address this, we performed a machine learning (ML)-based multimodal observational study to identify features associated with AD in 217 AmaXhosa children. Methods and findings: To gain deeper insights into AD pathogenesis, we re-analysed a previously established multimodal dataset comprising environmental, cytokine, antibody, and transcriptomic data from healthy AmaXhosa children and children with AD, aged 12–36 months, living in rural or urban settings. We applied ML to analyse each data modality individually and subsequently integrate them to identify multimodal signatures associated with AD. Specifically, we used the GeneSelectR workflow to identify informative genes, SHAP values to explain the ML outputs, and DIABLO to integrate the datasets and identify protective and susceptibility clusters. In the environmental and antibody datasets, we found that the combined effects of environmental features and higher levels of allergen-specific and total IgE antibodies contributed to the prediction of AD. In the transcriptomic dataset, we identified a subset of 560 genes that discriminated between children with and without AD and used these for the subsequent analyses. In the integrated analysis, we identified three multimodal clusters associated with AD status. One cluster associated with the healthy phenotype comprised environmental features primarily found in the rural setting, which correlated with plasma cytokine levels and the expression of autophagy-related genes. Two additional clusters were characterised by correlations between allergen-specific and total IgE antibodies and the cytokines MCP-4 and TARC, and by a transcriptomic feature signature associated with the AD endotype. Limitations of this study include the exploratory nature of the explainable ML framework and the lack of validation in an independent cohort. Conclusions: Complementary ML approaches enabled explainable analysis of a complex multimodal dataset. Integrated analyses identified a multimodal protective cluster comprising environmental, cytokine, and transcriptomic features, together with two AD susceptibility clusters, one dominated by transcriptomic features and the other by correlated cytokine and antibody levels. These findings improve our understanding of the factors associated with AD. Furthermore, the feature-selection and integration workflow provides a framework for analysing complex multimodal datasets in future biomedical research.

  • Open Access

    Consensus statements for the biopsychosocial care of patients with epidermolysis bullosa South Africa: Part 2

    by Antoinette V. Chateau, David Blackbeard, Carol Hlela, Martie Wege, Anne Armour, Thirona Naicker, Ncoza Dlova, Serantha Foolchand, Angela Chetty, Sarah Ainsworth, et al.

    Epidermolysis bullosa (EB) is a rare, incurable inherited mucocutaneous blistering disorder that can lead to multisystemic complications. In Africa, there are no established consensus statements or clinical guidelines for the care of patients with EB. To develop comprehensive transdisciplinary consensus statements for the care of patients with EB. This article (Part 2) presents 24 consensus statements focused on the biopsychosocial aspects of EB care. Part 1 addressed diagnostic and clinical management and resulted in 16 consensus statements. This was a multicentre, multiprovincial study involving healthcare practitioners from Eastern Cape, Free State, Gauteng, KwaZulu-Natal and Western Cape. In collaboration with patients and families, the transdisciplinary team of experts developed consensus-based statements through a modified Delphi process. This iterative process involved three consensus rounds with an 80% agreement threshold for each action point to ensure validity and reliability. In total, 24 consensus statements were endorsed. These included holistic patient and family care; cultural considerations; educational inclusion; paediatric and emergency care; psychosocial care; nutritional; gynaecological and ophthalmic support; occupational therapy; physiotherapy and orthopaedic; dental and podiatric management. Comprehensive transdisciplinary care is essential for addressing the holistic needs of patients with EB and their families, particularly in resource-limited and culturally diverse settings. This is the first set of consensus statements for the care of EB in South Africa and the broader African continent, offering a culturally sensitive, patient-centred framework for multidisciplinary care.

  • Open Access

    Consensus statements for the transdisciplinary care of patients with epidermolysis bullosa in South Africa: Part 1

    by Antoinette V. Chateau, Carol Hlela, Ncoza Dlova, Thuraya Isaacs, Thirona Naicker, Tracey Nupen, Julia Ambler, Frans Maruma, Lushen Pillay, Avumile Mankahla, et al.

    Background: Epidermolysis bullosa (EB) is a rare, painful and blistering genodermatosis with no cure. Treatment aims to prevent new lesions and manage complications. Previously, there were no management guidelines or consensus recommendations for patients with EB in Africa. Aim: The aim of this study is to produce a comprehensive, transdisciplinary and practical care guide that is contextually appropriate to the cultural setting and resource limitations in South Africa. Setting: Multicentre, multiprovincial study involving healthcare practitioners from five South African provinces – KwaZulu-Natal, Gauteng (Johannesburg, Pretoria), Western Cape (Cape Town, Stellenbosch), Free State (Bloemfontein) and the Eastern Cape (Umtata). Methods: Consensus recommendations for the care of patients with EB were developed by a transdisciplinary team of specialists in consultation with EB patients. The modified Delphi technique was used to reach a robust consensus with a threshold of 80% for each action point to ensure the validity and reliability of the recommendations. Results: In all, 16 consensus statements were developed, and the main themes included the clinical clues to the diagnosis, complications as per the subtype of EB, diagnostics in a resource-limited environment, management of EB, pruritus and pain, palliative care and genetic counselling. Conclusion: A transdisciplinary approach is essential for the holistic care of patients and their families with EB in the context of their resource limitations and cultural diversity providing much-needed guidance for clinicians in South Africa and similar settings. Contribution: This is the first consensus recommendation of care for patients with EB in Africa.


  • Presumed Levofloxacin-associated Lichenoid Drug Eruption in a Child With Rifampicin-resistant Tuberculosis

    by Joh-Nell Md van der Westhuizen, Mireille Porter, Elri Md Nortier, Liezel Md Coetzee, Carol Md Hlela, Rannakoe J. Lehloenya, Hendrik Simon Mmed Schaaf, Willem I. Mmed Visser


  • Associations between Environmental dust composition and Atopic Dermatitis in urban and rural settings

    by Thulja Trikamjee, Wisdom Basera, Maresa Botha, Heidi E. Facey‐Thomas, Ben Gaunt, Jon Genuneit, Claudia L. Gray, Sabelo Hadebe, Carol Hlela, Frank Kirstein, et al.

    Background: Environmental exposures are involved in the pathogenesis of the allergic phenotype and in determining which individual triggers a person becomes sensitized to. Atopic dermatitis (AD) may modulate these effects through increased penetration through the skin modifying the immune system and AD may be triggered or intensified by environmental exposures. These exposures and immune‐modulating factors may differ in urban and rural environments.Objectives: To compare house dust composition in urban and rural settings and correlate them with AD outcomes.Methods: Dust samples were collected from the beds of 156 children aged 6 months to 3 years. 42% of participants had atopic dermatitis. Samples were analyzed for bacterial endotoxin, fungal (β‐1,3‐glucan) levels, and house dust mite, cockroach, dog, cat, mouse, and peanut allergen. Exposures were compared in urban and rural environments and in participants with and without AD.Results: Endotoxin but not fungal β‐glucan exposure is higher in the environment of healthy controls than children with AD in both urban and rural settings. House dust mite allergen exposure is high in urban and rural settings with Dermatophagoides detected in 100% of samples. Cat and dog allergen exposure mirrors pet ownership patterns which differ slightly between groups and environments. Mouse allergen exposure is higher in urban homes.Conclusion: Environmental endotoxin may be protective against AD in both urban and rural settings. There are marked differences in allergen exposure in urban and rural settings, but these are unlikely to be important protective or risk factors.


  • Deep forehead lipomas in children—A series and review

    by Carol Hlela, Anthony J. Mancini

    Deep forehead lipomas are rare in children and may be confused with other more concerning soft tissue masses. We describe four children with deep forehead lipomas, diagnosed between 2 months and 1 year of age, three of them congenital. Notable findings included association with intracranial lipoma and seizures in one patient and the development of marked alopecia overlying the lipoma in another. While deep forehead lipomas may become less visible over time, alopecia and non‐syndromic extracutaneous involvement may be important associations.


  • Open Access

    A novel LYST mutation causing Chédiak Higashi syndrome in a South African child

    by Joycelyn Assimeng Dame, Lee-Ann Phillips, Nico de Villiers, Komala Pillay, Carol Hlela, Brian Eley


  • Microbiome and skin biology

    by Nonhlanhla Lunjani, Carol Hlela, Liam O’mAhony

    Purpose of review: The skin is home to a diverse milieu of bacteria, fungi, viruses, bacteriophages, and archaeal communities. The application of culture-independent approaches has revolutionized the characterization of the skin microbiome and have revealed a previously underappreciated phylogenetic and functional granularity of skin-associated microbes in both health and disease states. Recent findings: The physiology of a given skin-niche drives the site-specific differences in bacterial phyla composition of healthy skin. Changes in the skin microbiome have consistently been associated with atopic dermatitis. In particular, Staphylococcus aureus overgrowth with concomitant decline in Staphylococcus epidermidis is a general feature associated with atopic dermatitis and is not restricted to eczematous lesions. Changes in fungal species are now also being described. Changes in the composition and metabolic activity of the gut microbiota are associated with skin health. Summary: We are now beginning to appreciate the intimate and intricate interactions between microbes and skin health. Multiple studies are currently focused on the manipulation of the skin or gut microbiome to explore their therapeutic potential in the prevention and treatment of skin inflammation.


  • The prevalence of human T‐lymphotropic virus type 1 & 2 (HTLV‐1/2) in South African blood donors

    by Marion Vermeulen, Wendy Sykes, Charl Coleman, Brian Custer, Genevieve Jacobs, Jabulisile Jaza, Zhanna Kaidarova, Carol Hlela, Antoine Gessain, Olivier Cassar, et al.

    Background and objectives: Donated blood is not currently screened for human T‐cell lymphotropic virus (HTLV) in South Africa. Several small studies have detected HTLV‐1 in South Africa, but prevalence by geographic region or population group is unavailable.Materials and Methods: We performed a large seroprevalence study of South African blood donors during 3 months in 2013. All geographic regions except the Western Cape were included, and Black and Coloured (local term for mixed race) donors were oversampled. Identity‐unlinked plasma samples were screened with the Abbott Prism HTLV‐1/2 assay, and repeatedly reactive samples were tested by the Inno‐LIA HTLV‐1/2 Score confirmatory assay. Odds ratios were calculated with multivariable logistic regression.Results: Of 46 752 donors tested, 133 (0·28%) were initially reactive, 111 (0·24%) repeatedly reactive and 57 (0·12%) confirmed positive for HTLV‐1; none were HTLV‐2 positive. Prevalence was 0·062% weighted to annual blood donations but highly concentrated in the Black population group (OR = 20·24 CI: 2·77–147·88); higher in females than males (OR = 1·81 CI: 1·06–3·08); and in donors aged >50 years compared to ages 16–19 (OR = 6·4 CI: 2·95‐13·86). After controlling for age, sex and population group, there was no difference in prevalence between new and repeat blood donors or among geographic regions within South Africa.Conclusions: We conclude that HTLV‐1 infection is widespread among the Black population of South Africa and its epidemiology is similar to other endemic areas. Because South Africa is increasing its recruitment of Black blood donors, the implications for blood screening require further consideration.


  • Effects of diet on the childhood gut microbiome and its implications for atopic dermatitis

    by Mahboobeh Mahdavinia, Heather E. Rasmussen, Maresa Botha, Thi Dong Binh Tran, Jolice P. Van Den Berg, Erica Sodergren, Erika Davis, Krista Engen, Claudia Gray, Nonhlanhla Lunjani, et al.